The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415 · see citing works

Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice

Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,730 · see citing works

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066 · see citing works

Acute Respiratory Distress Syndrome

Ards Definition Task Force (2012) · JAMA · doi:10.1001/jama.2012.5669 · Cited by 8,806 · see citing works

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545 · see citing works

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068 · see citing works

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677 · see citing works

Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C.-K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.03.003 · Cited by 2,956 · see citing works

Coronavirus as a possible cause of severe acute respiratory syndrome

Peiris, M. J. S., Lai, S., Poon, L. L. M., Guan, Y., Yam, L., Lim, W., Nicholls, J. M., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,916 · see citing works

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,592 · see citing works

Coronaviruses post-SARS: update on replication and pathogenesis

Perlman, S. M., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,766 · see citing works

Coronaviruses — drug discovery and therapeutic options

Zumla, A. I., Chan, J. F., Azhar, E. I., Hui, D. S. C., & Yuen, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,689 · see citing works

Cytokine release syndrome

Shimabukuro‐Vornhagen, A., Gödel, P., Subklewe, M. S., Stemmler, H., Schlößer, H., Schlaak, M. S., Kochanek, M., Böll, B., & von Bergwelt‐Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,673 · see citing works

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,400 · see citing works

Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury

Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356 · see citing works

Cytokine storm and sepsis disease pathogenesis

Chousterman, B. G., Świrski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,340 · see citing works

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

Wong, C. K., LAM, C. W. K., Wu, A. K. L., Ip, W., Lee, N. L. S., Chan, I., Lit, L. C. W., Hui, D. S. C., Chan, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,270 · see citing works

Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus

Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256 · see citing works

SARS: systematic review of treatment effects

Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217 · see citing works

Age-dependent dysregulation of innate immunity

Shaw, A. C., Goldstein, D. R., & Montgomery, R. R. (2013) · Nature Reviews Immunology · doi:10.1038/nri3547 · Cited by 1,061 · see citing works

Sphingosine-1-phosphate signaling and its role in disease

Maceyka, M., Harikumar, K. B., Milstien, S., & Spiegel, S. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.003 · Cited by 1,039 · see citing works

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

Kuiken, T., Fouchier, R. A. M., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D. A. J., Laman, J. D., de Jong, T., van Doornum, G., Lim, W. W. L., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13967-0 · Cited by 1,015 · see citing works

Type 1 Interferons and the Virus-Host Relationship: A Lesson in Detente

García‐Sastre, A., & Biron, C. A. (2006) · Science · doi:10.1126/science.1125676 · Cited by 880 · see citing works

Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial*

Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867 · see citing works

Therapeutic siRNA silencing in inflammatory monocytes in mice

Leuschner, F., Dutta, P., Gorbatov, R., Novobrantseva, T. I., Donahoe, J. S., Courties, G., Lee, K. M., Kim, J. I., Markmann, J. F., Marinelli, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1989 · Cited by 839 · see citing works

Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury*

Parsons, P. E., Eisner, M. D., Thompson, B., Matthay, M. A., Ancukiewicz, M., Bernard, G. R., & Wheeler, A. P. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000149854.61192.dc · Cited by 723 · see citing works

Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm

Tanaka, T., Narazaki, M., & Kishimoto, T. (2016) · Immunotherapy · doi:10.2217/imt-2016-0020 · Cited by 708 · see citing works

[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].

Chen, L., Liu, H., Liu, W. Y., Liu, J., Liu, K., Shang, J., Deng, Y., & Wei, S. (2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0005 · Cited by 690 · see citing works

Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection

Teijaro, J. R., Walsh, K. B., Cahalan, S., Fremgen, D. M., Roberts, E., Scott, F., Martinborough, E., Peach, R., Oldstone, M. B. A., & Rosen, H. (2011) · Cell · doi:10.1016/j.cell.2011.08.015 · Cited by 688 · see citing works

Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)

Wan, S., Yi, Q., Fan, S., Lv, J., Zhang, X., Guo, L., Lang, C., Xiao, Q., Xiao, K., Yi, Z., et al. (2020) · doi:10.1101/2020.02.10.20021832 · Cited by 562 · see citing works

IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes

Channappanavar, R., Fehr, A. R., Zheng, J. H., Wohlford-Lenane, C., Abrahante, J. E., Mack, M., Sompallae, R. R., McCray, P. B., Meyerholz, D. K., & Perlman, S. M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126363 · Cited by 556 · see citing works

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study

Omrani, A. S., Saad, M. M., Baig, K. M., Bahloul, A., Abdul-Matin, M., Aidaroos, A. Y. A., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70920-x · Cited by 493 · see citing works

Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells

Law, H., Cheung, C. Y., Ng, H. Y., Sia, S. F., Chan, Y. O., Luk, W., Nicholls, J. M., Peiris, M. J. S., & Lau, Y. (2005) · Blood · doi:10.1182/blood-2004-10-4166 · Cited by 467 · see citing works

Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis

Cheung, C. Y., Poon, L. L. M., Ng, I. H. Y., Luk, W., Sia, S. F., Wu, M. H. S., Chan, K., Yuen, K., Gordon, S., Guan, Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7819-7826.2005 · Cited by 461 · see citing works

[Management of COVID-19: the Zhejiang experience].

Xu, K., Cai, H., Shen, Y., Ni, Q., Chen, Y., Hu, S., Li, J., Wang, H., Yu, L., Huang, H., et al. (2020) · PubMed Central · doi:10.3785/j.issn.1008-9292.2020.02.02 · Cited by 452 · see citing works

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques

Falzarano, D., de Wit, E., Rasmussen, A. L., Feldmann, F., Okumura, A., Scott, D. P., Brining, D., Bushmaker, T., Martellaro, C., Baseler, L. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3362 · Cited by 445 · see citing works

Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors

Lee, J. W., Fang, X., Krasnodembskaya, A. D., Howard, J. P., & Matthay, M. A. (2011) · Stem Cells · doi:10.1002/stem.643 · Cited by 430 · see citing works

Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis

Zhou, J., Chu, H., Li, C., Wong, B. H., Cheng, Z., Poon, V. K., Sun, T., Lau, C. C.-Y., Wong, K. K. Y., Chan, J. Y. W., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit504 · Cited by 425 · see citing works

Acute Respiratory Distress Syndrome in Critically Ill Patients With Severe Acute Respiratory Syndrome

Lew, T. W. K. (2003) · JAMA · doi:10.1001/jama.290.3.374 · Cited by 423 · see citing works

The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome

Wang, H., & Ma, S. (2008) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2007.10.031 · Cited by 408 · see citing works

Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment

Lau, S. K. P., Lau, C. C. Y., Chan, K., Li, C. P. Y., Chen, H., Jin, D., Chan, J. F., Woo, P. C. Y., & Yuen, K. (2013) · Journal of General Virology · doi:10.1099/vir.0.055533-0 · Cited by 393 · see citing works

Human immunopathogenesis of severe acute respiratory syndrome (SARS)

Cameron, M. J., Bermejo-Martin, J. F., Danesh, A., Muller, M. P., & Kelvin, D. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.02.014 · Cited by 391 · see citing works

Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014

Ng, D. L., Hosani, F. I. A., Keating, M. K., Gerber, S. I., Jones, T. L., Metcalfe, M. G., Tong, S., Tao, Y., Alami, N. N., Haynes, L. M., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.10.024 · Cited by 384 · see citing works

Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection

Drosten, C., Seilmaier, M., Corman, V. M., Hartmann, W. J., Scheible, G., Sack, S., Guggemos, W., Kallies, R., Muth, D., Junglen, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70154-3 · Cited by 382 · see citing works

Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand

Herold, S., Steinmueller, M., von Wulffen, W., Cakarova, L., Pinto, R., Pleschka, S., Mack, M., Kuziel, W. A., Corazza, N., Brunner, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080201 · Cited by 376 · see citing works

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

Min, C.-K., Cheon, S., Ha, N., Sohn, K. M., Kim, Y., Aigerim, A., Shin, H. M., Choi, J., Inn, K., Kim, J. H., et al. (2016) · Scientific Reports · doi:10.1038/srep25359 · Cited by 366 · see citing works

Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome

Zhang, Y., Li, J., Zhan, Y., Wu, L., Xue-ying, Y., Zhang, W., Ye, L., Xu, S., Sun, R., Wang, Y., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4410-4415.2004 · Cited by 336 · see citing works

Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates

Smits, S. L., de Lang, A., van den Brand, J. M. A., Leijten, L. M. E., van IJcken, W. F. J., Eijkemans, M. J. C., van Amerongen, G., Kuiken, T., Andeweg, A. C., Osterhaus, A. D. M. E., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000756 · Cited by 331 · see citing works

Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza

London, N. R., Zhu, W., Bozza, F. A., Smith, M. C. P., Greif, D. M., Sorensen, L. K., Chen, L., Kaminoh, Y., Chan, A. C., Passi, S. F., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000678 · Cited by 330 · see citing works

Characterization of Cytokine/Chemokine Profiles of Severe Acute Respiratory Syndrome

Jiang, Y., Xu, J., Zhou, C., Wu, Z., Zhong, S.-Q., Liu, J., Luo, W., Chen, T., Qin, Q., & Deng, P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-857oc · Cited by 317 · see citing works

Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome

Reghunathan, R., Jayapal, M., Hsu, L. Y., Chng, H. H., Tai, D. Y. H., Leung, B. P. L., & Melendez, A. J. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-2 · Cited by 295 · see citing works

Treatment of Severe Acute Respiratory Syndrome With Glucosteroids

Chen, R.-C., Tang, X.-P., Tan, S.-Y., Bi-ling, L., Wan, Z. Y., Fang, J.-Q., & Zhong, N. (2006) · CHEST Journal · doi:10.1378/chest.129.6.1441 · Cited by 275 · see citing works

[An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)].

(2020) · PubMed · doi:10.3760/cma.j.issn.0254-6450.2020.02.002 · Cited by 265 · see citing works

Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study

Arabi, Y. M., Shalhoub, S., Mandourah, Y., Al-Hameed, F. M., Al‐Omari, A., Qasim, E. A., Jose, J., Alraddadi, B. M., Almotairi, A., Khatib, K. A., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz544 · Cited by 248 · see citing works

IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment

Davidson, S., McCabe, T. M., Crotta, S., Gad, H. H., Hessel, E. M., Beinke, S., Hartmann, R., & Wack, A. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606413 · Cited by 240 · see citing works

Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus

Walsh, K. B., Teijaro, J. R., Wilker, P. R., Jatzek, A., Fremgen, D. M., Das, S. C., Watanabe, T., Hatta, M., Shinya, K., Suresh, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107024108 · Cited by 232 · see citing works

Clinical Disease in Children Associated With Newly Described Coronavirus Subtypes

Kuypers, J. M., Martin, E. T., Heugel, J., Wright, N. L., Morrow, R. A., & Englund, J. A. (2006) · PEDIATRICS · doi:10.1542/peds.2006-1406 · Cited by 231 · see citing works

Macrophage-expressed IFN-β Contributes to Apoptotic Alveolar Epithelial Cell Injury in Severe Influenza Virus Pneumonia

Högner, K., Wolff, T., Pleschka, S., Plog, S., Gruber, A. D., Kalinke, U., Walmrath, H., Bodner, J., Gattenlöhner, S., Lewe-Schlosser, P., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003188 · Cited by 228 · see citing works

Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome

Chien, J., Hsueh, P., Cheng, W., Yu, C., & Yang, P. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00942.x · Cited by 225 · see citing works

IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production

Blazek, K. D., Eames, H. L., Weiss, M., Byrne, A. J., Perocheau, D. P. B., Pease, J. E., Doyle, S. E., McCann, F. E., Williams, R. O., & Udalova, I. A. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20140995 · Cited by 217 · see citing works

The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study

Auyeung, T. W., Lee, J. S. W., Lai, W. K., Choi, C. H., Lee, H. K., Lee, J. S., Li, P. C. K., Lok, K. H., Yeung, Y. M., Wong, W. M., et al. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.09.008 · Cited by 208 · see citing works

High–Dose Pulse Versus Nonpulse Corticosteroid Regimens in Severe Acute Respiratory Syndrome

Ho, J., OOI, G. C., Mok, T., Chan, J. W. M., Hung, I. F., LAM, B. K., Wong, P. C., Li, P. C., Ho, P., Lam, W. K., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200306-766oc · Cited by 208 · see citing works

Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation

Marchingo, J. M., Sinclair, L. V., Howden, A. J. M., & Cantrell, D. A. (2020) · eLife · doi:10.7554/elife.53725 · Cited by 202 · see citing works

The immunomodulatory function of mesenchymal stem cells: mode of action and pathways

Uccelli, A., & de Rosbo, N. K. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12815 · Cited by 201 · see citing works

Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections

Davidson, S., Maini, M. K., & Wack, A. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0227 · Cited by 197 · see citing works

Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection

Kim, E. S., Choe, P. G., Park, W. B., Oh, H. S., Kim, E. J., Nam, E. Y., Na, S. H., Kim, M., Song, K., Bang, J. H., et al. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.11.1717 · Cited by 193 · see citing works

[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].

(2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0019 · Cited by 190 · see citing works

Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection

Rockx, B., Baas, T., Zornetzer, G. A., Haagmans, B. L., Sheahan, T. P., Frieman, M. B., Dyer, M. D., Teal, T. H., Proll, S. C., van den Brand, J. M. A., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00127-09 · Cited by 175 · see citing works

Cellular Inhibitor of Apoptosis Protein cIAP2 Protects against Pulmonary Tissue Necrosis during Influenza Virus Infection to Promote Host Survival

Rodrigue‐Gervais, I. G., Labbè, K., Dagenais, M., Dupaul-Chicoine, J., Champagne, C., Morizot, A., Skeldon, A. M., Brincks, E. L., Vidal, S. M., Griffith, T. S., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2013.12.003 · Cited by 161 · see citing works

Silencing of CCR2 in myocarditis

Leuschner, F., Courties, G., Dutta, P., Mortensen, L. J., Gorbatov, R., Sena, B. F., Novobrantseva, T. I., Borodovsky, A., Fitzgerald, K. J., Koteliansky, V., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu225 · Cited by 150 · see citing works

[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].

Zhao, J. P., Hu, Y., Du, R. H., Chen, Z. S., Jin, Y.-H., Zhou, M., Zhang, J., Qu, J. M., & Cao, B. (2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0007 · Cited by 149 · see citing works

Innate Immune Collectin Surfactant Protein D Simultaneously Binds Both Neutrophil Extracellular Traps and Carbohydrate Ligands and Promotes Bacterial Trapping

Douda, D. N., Jackson, R., Grasemann, H., & Palaniyar, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004201 · Cited by 127 · see citing works

Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection

Biggioggero, M., Crotti, C., Becciolini, A., & Favalli, E. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s150580 · Cited by 125 · see citing works

High Secretion of Interferons by Human Plasmacytoid Dendritic Cells upon Recognition of Middle East Respiratory Syndrome Coronavirus

Scheuplein, V., Seifried, J., Malczyk, A. H., Miller, L., Höcker, L., Vergara‐Alert, J., Dolnik, O., Zielecki, F., Becker, B., Spreitzer, I., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03607-14 · Cited by 123 · see citing works

Antitumor Necrosis Factor Therapy Is Associated With Improved Survival in Clinical Sepsis Trials

Qiu, P., Cui, X., Sun, J., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182982add · Cited by 115 · see citing works

Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial

Qin, Y., Zhou, Y., Lu, Y., Sun, F., Yang, S., Harypursat, V., & Chen, Y. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000791 · Cited by 101 · see citing works

Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong

Yam, L. Y.-C., Lau, A. C.-W., Lai, F. Y.-L., Shung, E., Chan, J., & Wong, V. C. W. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.01.005 · Cited by 100 · see citing works

Targeting Macrophage Subsets for Infarct Repair

Ben-Mordechai, T., Palevski, D., Glucksam, Y., Elron-Gross, I., Margalit, R., & Leor, J. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414534916 · Cited by 99 · see citing works

Changes in Cytokines, Haemodynamics and Microcirculation in Patients with Sepsis/Septic Shock Undergoing Continuous Renal Replacement Therapy and Blood Purification with CytoSorb

Zuccari, S., Damiani, E., Domizi, R., Scorcella, C., D'Arezzo, M., Carsetti, A., Pantanetti, S., Vannicola, S., Casarotta, E., Ranghino, A., et al. (2019) · Blood Purification · doi:10.1159/000502540 · Cited by 90 · see citing works

Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells

Tynell, J., Westenius, V., Rönkkö, E., Munster, V. J., Melén, K., Österlund, P., & Julkunen, I. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000351 · Cited by 88 · see citing works

Coronavirus Host Range Expansion and Middle East Respiratory Syndrome Coronavirus Emergence: Biochemical Mechanisms and Evolutionary Perspectives

Peck, K. M., Burch, C. L., Heise, M. T., & Baric, R. S. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055029 · Cited by 87 · see citing works

Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS

Wang, C., Liu, C., Wan, Y., Chou, C., Huang, K.-H., Lin, H.-C., Lin, S., Lin, T., Chung, K. F., & Kuo, H.-P. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-42 · Cited by 68 · see citing works

The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus

McDermott, J., Mitchell, H. D., Gralinski, L. E., Eisfeld, A. J., Josset, L., Bankhead, A., Neumann, G., Tilton, S. C., Schäfer, A., Li, C., et al. (2016) · BMC Systems Biology · doi:10.1186/s12918-016-0336-6 · Cited by 68 · see citing works

Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Wang, H., Liu, B., Tang, Y., Chang, P., Yao, L., Huang, B., Lodato, R. F., & Liu, Z. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01370 · Cited by 66 · see citing works

Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm

Walsh, K. B., Teijaro, J. R., Rosen, H., & Oldstone, M. B. A. (2011) · Immunologic Research · doi:10.1007/s12026-011-8240-z · Cited by 59 · see citing works

Influenza “Trains” the Host for Enhanced Susceptibility to Secondary Bacterial Infection

Shirey, K. A., Perkins, D. J., Lai, W., Zhang, W., Fernando, L. R., Gusovsky, F., Blanco, J. C. G., & Vogel, S. N. (2019) · mBio · doi:10.1128/mbio.00810-19 · Cited by 58 · see citing works

CORONAVIRUS-ASSOCIATED PNEUMONIA IN PREVIOUSLY HEALTHY CHILDREN

Heugel, J., Martin, E. T., Kuypers, J. M., & Englund, J. A. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318054e31b · Cited by 35 · see citing works

Ulinastatin ameliorates LPS‑induced pulmonary inflammation and injury by blocking the MAPK/NF‑κB signaling pathways in rats

Ju, M., He, H., Chen, S., Liu, Y., Liu, Y., Pan, S., Zheng, Y., Xuan, L., Zhu, D., & Luo, Z. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10561 · Cited by 24 · see citing works

Anti-TNF Therapy

Udalova, I., Monaco, C., Nanchahal, J., & Feldmann, M. (2016) · Microbiology spectrum · doi:10.1128/microbiolspec.mchd-0022-2015 · Cited by 20 · see citing works

Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors

Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., Melloni, E. M. T., Furlan, R., Ciceri, F., Rovere-Querini, P., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.037 · Cited by 1,804 · see citing works

Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review

Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2065 · Cited by 923 · see citing works

Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up

Mazza, M. G., Palladini, M., De Lorenzo, R., Magnaghi, C., Poletti, S., Furlan, R., Ciceri, F., Rovere-Querini, P., & Benedetti, F. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.02.021 · Cited by 513 · see citing works

Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?

Bajaj, V., Gadi, N., Spihlman, A. P., Wu, S. C., Choi, C. H., & Moulton, V. R. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.571416 · Cited by 476 · see citing works

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Nouta, J., Hoepel, W., Chen, H.-J., Linty, F., Visser, R., Brinkhaus, M., et al. (2021) · Science · doi:10.1126/science.abc8378 · Cited by 408 · see citing works

COVID-19 vaccines: The status and perspectives in delivery points of view

Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375 · see citing works

Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease

Chitimus, D. M., Popescu, M. R., Voiculescu, S. E., Panaitescu, A. M., Pavel, B., Zagrean, L., & Zagrean, A.-M. (2020) · Biomolecules · doi:10.3390/biom10091211 · Cited by 354 · see citing works

Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study

Hoertel, N., Sánchez-Rico, M., Vernet, R., Beeker, N., Jannot, A.-S., Neuraz, A., Salamanca, E., Paris, N., Daniel, C., Gramfort, A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01021-4 · Cited by 269 · see citing works

The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review

James, P. T., Ali, Z., Armitage, A. E., Bonell, A., Cerami, C., Drakesmith, H., Jobe, M., Jones, K. S., Liew, Z., Moore, S. E., et al. (2021) · The Journal of Nutrition · doi:10.1093/jn/nxab059 · Cited by 147 · see citing works

Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology

Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works

<scp>TNF</scp> ‐α/ <scp>IFN</scp> ‐γ synergy amplifies senescence‐associated inflammation and <scp>SARS‐CoV</scp> ‐2 receptor expression via hyper‐activated <scp>JAK</scp> / <scp>STAT1</scp>

Kandhaya‐Pillai, R., Yang, X., Tchkonia, T., Martin, G. M., Kirkland, J. L., & Oshima, J. (2022) · Aging Cell · doi:10.1111/acel.13646 · Cited by 119 · see citing works

Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection

Alquisiras-Burgos, I., Peralta-Arrieta, I., Alonso-Palomares, L. A., Zacapala-Gómez, A. E., Salmerón-Bárcenas, E. G., & Aguilera, P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02134-7 · Cited by 115 · see citing works

Biomarkers of post-covid depression

Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102 · see citing works

Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study

Moorlag, S. J. C. F. M., van Deuren, R. C., van Werkhoven, C. H., Jaeger, M., Debisarun, P., Taks, E., Mourits, V. P., Koeken, V. A. C. M., de Bree, L. C. J., ten Doesschate, T., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100073 · Cited by 96 · see citing works

A multiple-hit hypothesis involving reactive oxygen species and myeloperoxidase explains clinical deterioration and fatality in COVID-19

Goud, P. T., Bai, D., & Abu-Soud, H. M. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.51811 · Cited by 88 · see citing works

MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model

Kaspi, H., Semo, J., Abramov, N., Dekel, C., Lindborg, S., Kern, R., Lebovits, C., & Aricha, R. (2021) · Stem Cell Research &amp; Therapy · doi:10.1186/s13287-021-02143-w · Cited by 68 · see citing works

Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics

Yadav, P., Vats, R., Bano, A., & Bhardwaj, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118588 · Cited by 36 · see citing works

The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic

Mansour, H. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102195 · Cited by 3 · see citing works

Cytokine and cytokine storm after SARS-CoV-2 infection

Wang, Y. (2020) · Cited by 1 · see citing works

Pathogenesis of COVID-19 and multi-system inflammatory syndrome in children

Shankaralingappa, A., & Babu, T. A. (2021) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20211096 · Cited by 14 · see citing works

Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy

Miranda, D., & Sanchez, D. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89972-7.00006-4

Cytokine and cytokine storm

Wang, Y. (2020) · Tianjin yiyao · Cited by 4 · see citing works

Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases

Tang, X., Ji, T.-T., Dong, J.-R., Feng, H., Chen, F.-Q., Chen, X., Zhao, H., Chen, D., & Ma, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313009 · Cited by 102 · see citing works